Full Text
Pharmaceutical Industry\X92S Experiences With The Scientific Advice Offered By The Federal Joint Committee Within The Early Benefit Assessment Of Drugs In Germany

Abstract

Authors

C Dintsios S Schlenkrich

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×